Search Login Register

MK-7009 Summary

Description: inhibits hepatitis C virus NS3/4a protease; structure in first source

Also Known As: MK 7009; MK7009; vaniprevir

Networked: 14 relevant articles (6 outcomes, 6 trials/studies) for this Bio-Agent

Key Diseases for which MK-7009 is Relevant

  1. Infection : 5 outcomes 5 studies in 10 results
  2. Hepatitis C : 1 outcome in 5 results
  3. Fibrosis (Cirrhosis) : 1 outcome in 2 results
  4. Chronic Hepatitis C : 1 study in 2 results
  5. Body Weight (Weight, Body) : 1 study in 1 result
Show All >>

Drugs Related to MK-7009

  1. Ribavirin (Virazole)
  2. Interferons
  3. MK-7009
  4. Protease Inhibitors (Protease Inhibitor)
  5. telaprevir
  6. Antiviral Agents (Antivirals)
  7. N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamide
  8. N- (17- (2- (4- isopropylthiazole- 2- yl)- 7- methoxy- 8- methylquinolin- 4- yloxy)- 13- methyl- 2,14- dioxo- 3,13- diazatricyclo(13.3.0.04,6)octadec- 7- ene- 4- carbonyl)(cyclopropyl)sulfonamide
  9. peginterferon alfa-2a (Pegasys)
  10. Serine Proteinase Inhibitors (Serine Protease Inhibitors)
Show All >>

Therapies Related to MK-7009

  1. Aftercare (After-Treatment)

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.